Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CHF | -6.78% | -4.51% | +34.15% |
17/04 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
17/04 | Swiss Court OKs Moratorium Extension for Spexis | MT |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Other languages